Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response

被引：2
|
作者：
Radtke, Marc [1 ]
Conrad, Curdin [2 ]
Schuster, Christopher [3 ,4 ]
Saure, Daniel [3 ]
Mert, Can [5 ]
Riedl, Elisabeth [3 ,4 ]
Costanzo, Antonio [6 ,7 ]
机构：
[1] Dermatol Hamburg GmbH, Hamburg, Germany
[2] CHU Vaudois, Lausanne, Switzerland
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[5] HaaPacs GmbH, Schriesheim, Germany
[6] Humanitas Univ, Milan, Italy
[7] IRCCS Humanitas Res Hosp, Milan, Italy
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2022年 / 33卷 / 02期
关键词：
D O I：
10.1080/09546634.2020.1782317
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1168 / 1170
页数：3
相关论文
共 50 条
  • [1] Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
    Goadsby, Peter J.
    Dodick, David W.
    Martinez, James M.
    Ferguson, Margaret B.
    Oakes, Tina M.
    Zhang, Qi
    Skljarevski, Vladimir
    Aurora, Sheena K.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (08): : 939 - 944
  • [2] Comparison of efficacy of ixekizumab and ustekinumab in the treatment of plaque psoriasis: An indirect comparison via etanercept
    Schacht, Alexander
    Petto, Helmut
    Brnabic, Alan
    Kadziola, Zbigniew
    Mallbris, Lotus
    Wilhelm, Stefan
    Dutronc, Yves
    Hartz, Susan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB241 - AB241
  • [3] Ustekinumab as a Treatment for Ixekizumab-Associated New-Onset Crohn's Disease in a Patient with Psoriasis
    Tan, Justin Ryan L.
    Alba, Willy S.
    ACG CASE REPORTS JOURNAL, 2024, 11 (02)
  • [4] Lurasidone in the treatment of bipolar depression: A post-hoc analysis by duration of illness
    Hagi, Katsuhiko
    Shima, Hirokazu
    BIPOLAR DISORDERS, 2021, 23 : 92 - 93
  • [5] Stability of PASI 90 response in psoriasis patients treated with ixekizumab or ustekinumab
    Gottlieb, A.
    Rosmarin, D.
    Muram, T.
    Lin, C.
    Shrom, D. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S97 - S97
  • [6] Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3
    Egeberg, Alexander
    Kristensen, Lars Erik
    Vender, Ron
    Zaheri, Shirin
    EL Baou, Celine
    Gallo, Gaia
    Riedl, Elisabeth
    Schuster, Christopher
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [7] Duration of response - application of adjusted Kaplan Meier curves comparing ixekizumab and ustekinumab
    Radtke, M.
    Conrad, C.
    Schuster, C.
    Murphy, K.
    Costanzo, A.
    Norman, J.
    Raniga, J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 101 - 101
  • [8] Role of Concomitant Immunosuppression in the Efficacy and Safety of Ustekinumab: Post-Hoc Analyses of UNITI
    Hanauer, Stephen
    Sattin, Bernie
    Jacobstein, Douglas
    Gao, Long-Long
    Gasink, Christopher
    Rutgeerts, Paul
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S63 - S63
  • [9] Post-hoc comparison tests for odds ratios
    Yilmaz, Ayfer Ezgi
    Altunay, Serpil Aktas
    ELECTRONIC JOURNAL OF APPLIED STATISTICAL ANALYSIS, 2022, 15 (01) : 75 - 94
  • [10] Baseline characteristics of patients with moderate to severe plaque psoriasis: post-hoc analysis of response to etanercept
    Gisondi, Paolo
    Girolomoni, Giampiero
    de Vlam, Kurt
    Al Hammadi, Anwar
    Carneiro, Sueli
    Arenberger, Petr
    Gallo, Gaia
    Jones, Heather
    Hsu, Ming-Ann
    Ferdousi, Tahmina
    Szumski, Annette
    Chhabra, Amit
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S26 - S26
12345